Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.6800
+0.0020 (0.29%)
Oct 22, 2026, 5:35 PM CEST
Transgene Market Cap
Transgene has a market cap or net worth of €186.24 million as of October 22, 2026. It is the 20,365th most valuable company in the world and the 243rd biggest in France. Its market cap has increased by 3.83% in one year.
Market Cap
186.24M
Enterprise Value
95.58M
Revenue
5.62M
Global Rank
Country Rank
#243 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 186.24M, an increase of 22.64%. That is a compound annual growth rate of 0.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 186.24M | -29.15% |
| Dec 31, 2025 | 262.87M | 192.89% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 646.23M |
| DBV Technologies | 471.98M |
| Valneva SE | 464.63M |
| Genfit | 435.27M |
| Valerio Therapeutics Société anonyme | 204.77M |
| Innate Pharma | 118.44M |
| Sensorion | 93.38M |
| ABIONYX Pharma | 67.66M |